These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25837484)

  • 1. Negative feedback loop between p66Shc and ZEB1 regulates fibrotic EMT response in lung cancer cells.
    Li X; Gao D; Wang H; Li X; Yang J; Yan X; Liu Z; Ma Z
    Cell Death Dis; 2015 Apr; 6(4):e1708. PubMed ID: 25837484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epithelial to mesenchymal transition markers are associated with an increased metastatic risk in primary cutaneous squamous cell carcinomas but are attenuated in lymph node metastases.
    Toll A; Masferrer E; Hernández-Ruiz ME; Ferrandiz-Pulido C; Yébenes M; Jaka A; Tuneu A; Jucglà A; Gimeno J; Baró T; Casado B; Gandarillas A; Costa I; Mojal S; Peña R; de Herreros AG; García-Patos V; Pujol RM; Hernández-Muñoz I
    J Dermatol Sci; 2013 Nov; 72(2):93-102. PubMed ID: 23928229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of LKB1 in epithelial-mesenchymal transition (EMT) of human lung cancer cells.
    Roy BC; Kohno T; Iwakawa R; Moriguchi T; Kiyono T; Morishita K; Sanchez-Cespedes M; Akiyama T; Yokota J
    Lung Cancer; 2010 Nov; 70(2):136-45. PubMed ID: 20207041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of the polycomb protein Mel-18 enhances the epithelial-mesenchymal transition by ZEB1 and ZEB2 expression through the downregulation of miR-205 in breast cancer.
    Lee JY; Park MK; Park JH; Lee HJ; Shin DH; Kang Y; Lee CH; Kong G
    Oncogene; 2014 Mar; 33(10):1325-35. PubMed ID: 23474752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
    Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
    Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-200c suppresses TGF-β signaling and counteracts trastuzumab resistance and metastasis by targeting ZNF217 and ZEB1 in breast cancer.
    Bai WD; Ye XM; Zhang MY; Zhu HY; Xi WJ; Huang X; Zhao J; Gu B; Zheng GX; Yang AG; Jia LT
    Int J Cancer; 2014 Sep; 135(6):1356-68. PubMed ID: 24615544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of Git2 induces epithelial-mesenchymal transition by miR146a-Cnot6L-controlled expression of Zeb1.
    Zhou W; Thiery JP
    J Cell Sci; 2013 Jun; 126(Pt 12):2740-6. PubMed ID: 23591815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epithelial-mesenchymal transition and tumor suppression are controlled by a reciprocal feedback loop between ZEB1 and Grainyhead-like-2.
    Cieply B; Farris J; Denvir J; Ford HL; Frisch SM
    Cancer Res; 2013 Oct; 73(20):6299-309. PubMed ID: 23943797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Zinc finger E-box binding homeobox 1 promotes invasion and bone metastasis of small cell lung cancer in vitro and in vivo.
    Liu Y; Zhang N; Wang Y; Xu M; Liu N; Pang X; Cao J; Ma N; Pang H; Liu L; Zhang H
    Cancer Sci; 2012 Aug; 103(8):1420-8. PubMed ID: 22632166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma.
    Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q
    Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical analysis of the expression of E-cadherin and ZEB1 in non-small cell lung cancer.
    Matsubara D; Kishaba Y; Yoshimoto T; Sakuma Y; Sakatani T; Tamura T; Endo S; Sugiyama Y; Murakami Y; Niki T
    Pathol Int; 2014 Nov; 64(11):560-8. PubMed ID: 25347933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The nuclear protein expression levels of SNAI1 and ZEB1 are involved in the progression and lymph node metastasis of cervical cancer via the epithelial-mesenchymal transition pathway.
    Chen Z; Li S; Huang K; Zhang Q; Wang J; Li X; Hu T; Wang S; Yang R; Jia Y; Sun H; Tang F; Zhou H; Shen J; Ma D; Wang S
    Hum Pathol; 2013 Oct; 44(10):2097-105. PubMed ID: 23791009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZEB1 represses E-cadherin and induces an EMT by recruiting the SWI/SNF chromatin-remodeling protein BRG1.
    Sánchez-Tilló E; Lázaro A; Torrent R; Cuatrecasas M; Vaquero EC; Castells A; Engel P; Postigo A
    Oncogene; 2010 Jun; 29(24):3490-500. PubMed ID: 20418909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EMT-activator ZEB1 induces bone metastasis associated genes including BMP-inhibitors.
    Mock K; Preca BT; Brummer T; Brabletz S; Stemmler MP; Brabletz T
    Oncotarget; 2015 Jun; 6(16):14399-412. PubMed ID: 25973542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological significance of ZEB1 protein in patients with hepatocellular carcinoma.
    Zhou YM; Cao L; Li B; Zhang RX; Sui CJ; Yin ZF; Yang JM
    Ann Surg Oncol; 2012 May; 19(5):1700-6. PubMed ID: 21584833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel ZEB1/HAS2 positive feedback loop promotes EMT in breast cancer.
    Preca BT; Bajdak K; Mock K; Lehmann W; Sundararajan V; Bronsert P; Matzge-Ogi A; Orian-Rousseau V; Brabletz S; Brabletz T; Maurer J; Stemmler MP
    Oncotarget; 2017 Feb; 8(7):11530-11543. PubMed ID: 28086235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. β-arrestin-1 mediates nicotine-induced metastasis through E2F1 target genes that modulate epithelial-mesenchymal transition.
    Pillai S; Trevino J; Rawal B; Singh S; Kovacs M; Li X; Schell M; Haura E; Bepler G; Chellappan S
    Cancer Res; 2015 Mar; 75(6):1009-20. PubMed ID: 25600647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-cadherin, beta-catenin, and ZEB1 in malignant progression of cancer.
    Schmalhofer O; Brabletz S; Brabletz T
    Cancer Metastasis Rev; 2009 Jun; 28(1-2):151-66. PubMed ID: 19153669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic and pharmacologic inhibition of mTORC1 promotes EMT by a TGF-β-independent mechanism.
    Mikaelian I; Malek M; Gadet R; Viallet J; Garcia A; Girard-Gagnepain A; Hesling C; Gillet G; Gonzalo P; Rimokh R; Billaud M
    Cancer Res; 2013 Nov; 73(22):6621-31. PubMed ID: 24078802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of a PEAK1/ZEB1 signaling axis during TGFβ/fibronectin-induced EMT in breast cancer.
    Agajanian M; Runa F; Kelber JA
    Biochem Biophys Res Commun; 2015 Sep; 465(3):606-12. PubMed ID: 26297948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.